CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 54 filers reported holding CABALETTA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,260,680 | +17.9% | 1,594,000 | 0.0% | 0.14% | +17.6% |
| Q2 2023 | $20,578,540 | +85.1% | 1,594,000 | +18.6% | 0.12% | +98.3% |
| Q1 2023 | $11,114,880 | -10.6% | 1,344,000 | 0.0% | 0.06% | -20.0% |
| Q4 2022 | $12,432,000 | +2791.2% | 1,344,000 | +103.0% | 0.08% | +2400.0% |
| Q3 2022 | $430,000 | -38.7% | 662,063 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $702,000 | -47.8% | 662,063 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $1,344,000 | -46.4% | 662,063 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $2,509,000 | -68.8% | 662,063 | 0.0% | 0.01% | -65.7% |
| Q3 2021 | $8,051,000 | +47.1% | 662,063 | +4.0% | 0.04% | +45.8% |
| Q2 2021 | $5,473,000 | -22.5% | 636,363 | 0.0% | 0.02% | -22.6% |
| Q1 2021 | $7,064,000 | -11.1% | 636,363 | 0.0% | 0.03% | +3.3% |
| Q4 2020 | $7,942,000 | +15.1% | 636,363 | 0.0% | 0.03% | +7.1% |
| Q3 2020 | $6,898,000 | -2.7% | 636,363 | 0.0% | 0.03% | -9.7% |
| Q2 2020 | $7,089,000 | +52.6% | 636,363 | 0.0% | 0.03% | +6.9% |
| Q1 2020 | $4,645,000 | -47.8% | 636,363 | 0.0% | 0.03% | -38.3% |
| Q4 2019 | $8,890,000 | – | 636,363 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |